Skip to main content

Table 3 10-year fracture risk for women in the non-treatment group* based on their frailty status (low vg high) at age 75

From: Can frailty in conjunction with FRAX identify additional women at risk of fracture - a longitudinal cohort study of community dwelling older women

Frailty range

Non-treatment and LOW frailty*

Non-treatment and HIGH frailty*

Fracture Risk

 

(0.00–0.27)

n = 356

(> 0.28)

n = 94

HR (95% CI)

Fractures

 No with Hip fx (10y)

37/443

(8%)

17/121

(14%)

2.01 (1.13–3.57)

p < 0.018

 No with MOF (10y)

117/443

(26%)

39/121

(32%)

1.40 (0.97–2.01)

p < 0.072

  1. *The non-treatment group was identified using the Swedish Osteoporosis Foundation and include those with no previous MOFs and either a FRAXMOF < 15% or did not meet requirements for treatment after BMD measurement (i.e. T-score < − 2.5 and FRAXMOF BMD > 20%). Low frailty includes Q1-Q3 and high frailty is Q4. Hazard ratios are unadjusted, comparing Q4 to Q1-Q3
Back to article page